Publications (23)32.45 Total impact
-
Article: Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer.
[show abstract] [hide abstract]
ABSTRACT: Growing evidence suggests that phospholipase A2 (PLA2) plays a pivotal role in tumorigenesis in human gastrointestinal cancer. One of the well-studied isoforms of PLA2, group IIA PLA2 (PLA2G2A), appears to exert its protumorigenic or antitumorigenic effects in a tissue-specific manner. The present study was designed to determine the expression profile and prognostic value of PLA2G2A in gastric cancer in a large Chinese cohort. By using real-time polymerase chain reaction, the amount of PLA2G2A messenger RNA in 60 pairs of fresh gastric tumors and adjacent noncancerous mucosa was measured. The immunostaining of PLA2G2A in 866 gastric cancers with paired noncancerous tissues was assayed. No expression of PLA2G2A was found in normal gastric mucosa, and focal expression of PLA2G2A was noticed in intestinal metaplasia, whereas significantly increased expression of PLA2G2A was observed in the cytoplasm of gastric cancer cells. Furthermore, the extent of PLA2G2A expression was associated with tumor size (P < .001), tumor differentiation (P = .001), T class (P < .001), N class (P < .001), and TNM stage (P < .001) of gastric cancer. Multivariate analysis showed that PLA2G2A expression was an independent predictor of survival for patients with gastric cancer (P = .024). Expression of PLA2G2A seems to be protective for patients with gastric cancer (hazard ratio, 1.423; 95% confidence interval, 1.047-1.935), and it may be a target for achieving better treatment outcomes.Human pathology 05/2013; · 3.03 Impact Factor -
Article: Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.
[show abstract] [hide abstract]
ABSTRACT: Arachidonic acid metabolic pathway has been implicated in the inflammation-associated tumorigenesis of gastrointestinal cancers. As the rate-limiting enzyme of arachidonic acid production, group IVA phospholipase A2 (PLA2G4A) is hypothesized to play a fundamental role in gastric tumorigenesis as well as cyclooxygenase-2 (COX-2). However, little is known about the expression and role of PLA2G4A in gastric cancer, and the association of PLA2G4A with COX-2 remains to be elucidated. In this study, the mRNA expression of PLA2G4A and COX-2 in 60 pairs of fresh gastric tumors and corresponding adjacent non-cancerous mucosa was detected by using real-time quantitative PCR and the immunostaining of the both proteins in paired samples from 866 gastric cancer patients were assessed by using immunohistochemistry method. The clinicopathological and the prognostic relevance of PLA2G4A and COX-2 expression were determined. The results revealed a significantly reduced expression of PLA2G4A in gastric tumors compared to in non-cancerous tissues, as opposite to the increased expression of COX-2. PLA2G4A was significantly associated with tumor size (P = 0.003), tumor grade (P < 0.001), intestinal type (P = 0.003), T classification (P < 0.001), N classification (P < 0.001), and thereby TNM stage (P < 0.001). PLA2G4A and COX-2 expression were both identified as independent prognostic factors in multivariate Cox model analysis (P = 0.024 for PLA2G4A and P < 0.001 for COX-2). Moreover, the reduced PLA2G4A and increased COX-2 expression was both associated with unfavorable survival for patients with gastric cancer. PLA2G4A might serve as a promising target for future therapeutic approaches to gastric cancer combined with COX-2 inhibitors.Medical Oncology 03/2013; 30(1):454. · 2.14 Impact Factor -
Article: Expression profile and prognostic role of sex hormone receptors in gastric cancer.
[show abstract] [hide abstract]
ABSTRACT: BACKGROUND: Increasing interest has been devoted to the expression and possible role of sex hormone receptors in gastric cancer, but most of these findings are controversial. In the present study, the expression profile of sex hormone receptors in gastric cancer and their clinicopathological and prognostic value were determined in a large Chinese cohort. METHODS: The mRNA and protein expression of estrogen receptor alpha (ERalpha), estrogen receptor beta (ERbeta), progesterone receptor (PR), and androgen receptor (AR) in primary gastric tumors and corresponding adjacent normal tissues from 60 and 866 Chinese gastric cancer patients was detected by real-time quantitative PCR and immunohistochemistry method, respectively. The expression profile of the four receptors was compared and their associations with clinicopathological characteristics were assessed by using Chi-square test. The prognostic value of the four receptors in gastric cancer was evaluated by using univariate and multivariate Cox regression analysis. RESULTS: The presence of ERalpha, ERbeta, PR, and AR in both gastric tumors and normal tissues was confirmed but their expression levels were extremely low except for the predominance of ERbeta. The four receptors were expressed independently and showed a decreased expression pattern in gastric tumors compared to adjacent normal tissues. The positive expression of the four receptors all correlated with high tumor grade and intestinal type, and ERalpha and AR were also associated with early TNM stage and thereby a favorable outcome. However, ERalpha and AR were not independent prognostic factors for gastric cancer when multivariate survival analysis was performed. CONCLUSIONS: Our findings indicate that the sex hormone receptors may be partly involved in gastric carcinogenesis but their clinicopathological and prognostic significance in gastric cancer appears to be limited.BMC Cancer 12/2012; 12(1):566. · 3.01 Impact Factor -
Article: Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial.
[show abstract] [hide abstract]
ABSTRACT: The efficacy and safety of bevacizumab with modified irinotecan, leucovorin bolus, and 5-fluorouracil intravenous infusion (mIFL) in the first-line treatment of metastatic colorectal cancer (mCRC) has not been well evaluated in randomized clinical trials in Chinese patients. We conducted a phrase III trial in which patients with previously untreated mCRC were randomized 2:1 to the mIFL [irinotecan (125 mg/m(2)), leucovorin (20 mg/m(2)) bolus, and 5-fluorouracil intravenous infusion (500 mg/m(2)) weekly for four weeks every six weeks] plus bevacizumab (5 mg/kg every two weeks) group and the mIFL group, respectively. Co-primary objectives were progression-free survival (PFS) and 6-month PFS rate. In total, 214 patients were enrolled. Our results showed that addition of bevacizumab to mIFL significantly improved median PFS (4.2 months in the mIFL group vs. 8.3 months in the bevacizumab plus mIFL group, P < 0.001), 6-month PFS rate (25.0% vs. 62.6%, P < 0.001), median overall survival (13.4 months vs. 18.7 months, P = 0.014), and response rate (17% vs. 35%, P = 0.013). Grades 3 and 4 adverse events included diarrhea (21% in the mIFL group and 26% in the bevacizumab plus mIFL group) and neutropenia (19% in the mIFL group and 33% in the bevacizumab plus mIFL group). No wound-healing complications or congestive heart failure occurred. Our results suggested that bevacizumab plus mIFL is effective and well tolerated as first-line treatment for Chinese patients with mCRC. Clinical benefit and safety profiles were consistent with those observed in pivotal phase III trials with mainly Caucasian patients.Chinese journal of cancer 10/2011; 30(10):682-9. -
Article: Effect of sunitinib combined with ionizing radiation on endothelial cells.
[show abstract] [hide abstract]
ABSTRACT: The aims of present study were to evaluate the efficacy of combining sunitinib with ionizing radiation (IR) on endothelial cells in vitro and in vivo. Human umbilical vein endothelial cells (HUVECs) were exposed to IR with or without sunitinib pretreatment. Apoptosis assay and cell cycle distribution were analyzed by flow cytometry. Clonogenic survival assay at 3 Gy dose with or without sunitinib was performed. The activity of phosphatidylinositol 3-kinase (PI3K)/Akt signal pathway was detected by Western immunoblot. Lewis lung carcinoma mouse model was built to examine the effect of combination therapy on endothelial cells in vivo. Microvasculature changes were detected by immunohistochemistry using anti-CD31 antibody. Our results showed combination therapy of sunitinib and IR significantly increased apoptosis of endothelial cells and inhibited colony formation compared to sunitinib or radiotherapy alone. It also resulted in cell cycle redistribution (decreasing cells in S phase and increasing cells in G2/M phase). The activity of PI3K/Akt signal pathway was inhibited, which could be the potential mechanisms that account for the enhanced radiation response induced by sunitinib. In vivo analysis showed that combination therapy significantly decreased microvasculature formation. The results demonstrated that combination therapy of sunitinib and IR has the potential to increase the cytotoxic effects on endothelial cells.Journal of Radiation Research 01/2011; 52(1):1-8. · 1.68 Impact Factor -
Article: A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer.
[show abstract] [hide abstract]
ABSTRACT: The prediction of chemosensitivity is a challenging problem in the management of cancer. In the present study, a metabonomic approach was proposed to assess the feasibility of chemosensitivity prediction in a human xenograft model of gastric cancer. BALB/c-nu/nu mice were transplanted with MKN-45 cell line to establish the xenograft model. The mice were then randomized into treatment group (cisplatin and 5-fluorouracil) and control group (0.9% sodium chloride), and their plasma were collected before treatment. Metabolic profiles of all plasma samples were acquired by using high-performance liquid chromatography coupled with a quadrupole time-of-flight mass spectrometer (HPLC/Q-TOF-MS). Based on the data of metabolic profiles and k-Nearest Neighbor algorithm, a prediction model for chemosensitivity was developed and an average accuracy of 90.4% was achieved. In addition, a series of endogenous metabolites, including 1-acyl-lysophosphatidycholines, polyunsaturated fatty acids and their derivatives, were determined as potential indicators of chemosensitivity. In conclusion, our results suggest that the proposed metabonomic approach allows effective chemosensitivity prediction in human xenograft model of gastric cancer. The approach presents a new concept in the chemosensitivtiy prediction of cancer and is expected to be developed as a powerful tool in the personalized cancer therapy.International Journal of Cancer 12/2010; 127(12):2841-50. · 5.44 Impact Factor -
Article: The p300/CBP associated factor: is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome.
[show abstract] [hide abstract]
ABSTRACT: Objectives: To investigate the expression of P300/CBP-associated factor (PCAF) protein in intestinal type gastric cancer (ITGC); analyze the relationship between the expression of PCAF protein and the clinical pathological characteristics of patients; explore the effects of PCAF protein on biological behaviors of ITGC. Results: The expression of PCAF was markedly downregulated in GC cell lines and ITGC tissues. PCAF was able to suppress tumorigenicity of GC cells both in vitro and in vivo, including colony formation in soft agar and tumor formation in nude mice. PCAF could also inhibit GC cells entering S phase from G1 phase. Statistical analysis displayed a significant correlation in PCAF expression with the gastric wall invasion, tumor size, TNM stage, p21, pRb (p < 0.001) and PCNA (p < 0.01) in ITGC specimens. A reduced PCAF protein expression correlated significantly with a mutant type p53 protein expression (p < 0.01). Univariate analysis indicated that the patients demonstrating the high-PCAF/wild type p53 expression have a significantly (p < 0.0001) better overall survival (OS), while multivariate analysis indicated that the location, lymph node metastasis, PCAF/p53 (p < 0.0001), gastric wall invasion (p = 0.001) and PCNA (p = 0.018) are independently significant prognostic factors for OS. Methods: Immunohistochemistry was performed to evaluate the expression of PCAF in a large subset containing 406 ITGC samples. Eukaryotic expression plasmid pcDNA3.1/PCAF was constructed and transfected into the human gastric cancer cell line SGC-7901 and protein expression was detected by western blot. The proliferation and cell cycle of gastric cancer cells were evaluated by MTT assay and flow cytometry. Tumor growth in nude mice was used to access the tumorigenicity of gastric cancer cells. Apoptosis cells were detected by TUNEL staining. Conclusion: Reduced expression of PCAF plays an important role in the development of ITGC and correlates with a poor clinical outcome.Cancer biology & therapy 02/2010; 9(4). · 2.64 Impact Factor -
Article: Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: an analysis based on a Chinese population.
[show abstract] [hide abstract]
ABSTRACT: To determine the prognostic value of the ratio of metastatic lymph nodes (RML) for gastric cancer and compare it to the prognostic value of the number-based pN classification. The survival of 513 patients who underwent curative resection between 2000 and 2005 was retrieved. The prognostic value of two factors for nodal status: RML classification (RML0, 0%; RML1, < or =30%; RML2, < or =50%; RML3, >50%) and pN classification (6th TNM system), was analyzed. Both RML and pN classifications were independent prognostic factors when considered separately in multivariate analysis (P-values < 0.05). Moreover, the proportion of explained variation (PEV) analysis showed that each classification had more prognostic value than other prognostic factors in two models respectively (P-values < 0.05). The D-measure for prognostic separation was 1.563 versus 1.383 for RML versus pN. Bootstrap results for the difference of D-measures did not show a significant difference between RML and pN in terms of prognostic power (95% CI, -0.102 to 0.175). RML is an independent prognostic factor for gastric cancer. However, no significant evidence is found to support the hypothesis that RML classification carries more prognostic value than pN classification.Journal of Surgical Oncology 02/2009; 99(6):329-34. · 2.10 Impact Factor -
Article: Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
[show abstract] [hide abstract]
ABSTRACT: Zoledronic acid (Zometa, ZOL) and cytotoxic chemotherapy agents have been reported to have synergistic antitumor activities. However, there is limited data on the effects of combination therapies on the development of bone metastasis in animal models of lung cancer. The purpose of this study was to establish a human lung adenocarcinoma cell line with high bone metastatic potential in an immunodeficient mouse model and to evaluate the synergistic inhibitory activity of zoledronate and paclitaxel (P) on bone metastasis in nude mice. A human lung adenocarcinoma cell line with high bone metastatic potential (SPC-A1-BM) was established by 10 rounds of in vivo selection. Cells were inoculated into the cardiac ventricle of NIH-BNX mice, which were treated 8 days later with: ZOL (0.2 mg/kg s.c. twice weekly) alone, P (6.0 mg/kg every week, i.p.) alone, P + ZOL, or vehicle (10 mice per group). Tumor growth was evaluated with bone scans, X-rays and in situ immunohistochemistry. Serum n-telopeptide of type I collagen (NTX) was measured by ELISA. Survival was assessed using the Kaplan-Meier method. Bone scan, radiographic and histological assessments revealed fewer bone metastases in all treatment groups vs. vehicle, with P + ZOL significantly reducing the incidence of bone metastases detected by bone scans (P=0.020) and X-rays (P=0.036). A histological analysis revealed marginal differences in the number of bone metastases between P + ZOL and vehicle (P=0.058). There was a trend towards differences in survival between the groups (P=0.1511) and survival was significantly longer for the P + ZOL group vs. vehicle (P=0.022). Compared with vehicle and ZOL alone, cancerous cells in the bone of mice treated with P + ZOL expressed higher levels of Bax and lower levels of Bcl-2 and Bcl-xl. ZOL produced a trend towards reduced NTX levels vs. vehicle and P + ZOL produced a profound reduction in NTX vs. vehicle (P=0.022). The results of this study indicated that zoledronate enhanced the efficacy of paclitaxel synergistically, by reducing the incidence of bone metastasis from lung cancer and prolonging survival in a mouse model of non-small cell lung cancer with a high potential for metastasis to bone.Oncology Reports 10/2008; 20(3):581-7. · 1.84 Impact Factor -
Article: A common misuse of stepwise regression in studies of ratio of metastatic lymph nodes for gastric cancer.
Annals of Surgical Oncology 07/2008; 15(6):1805-6. · 4.17 Impact Factor -
Article: New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma.
[show abstract] [hide abstract]
ABSTRACT: Metastasis-associated genomic alterations have been recognized to play a critical role in tumor metastasis. Primary and metastatic tumor cells in mice and tumors in a patient were studied by cDNA array analysis. Selected genes were determined by RT-PCR and immunohistochemistry. Pathways on changed genes were statistically analyzed. The function of Grb2 was determined by in vitro wound assay. Nodal metastatic cells had a stronger ability of growth and metastasis than primary tumor cells. A total of 376 genes showed a different expression between primary and metastatic cells. The expression of Grb2 and genes in the Grb2-mediated pathways was significantly elevated in the metastases. Elevated levels of Grb2 expression in metastases were related to the distant metastasis of colorectal carcinoma. Blocking the Grb2-SH2 domain signaling transduction inhibited cell motility. Metastasis-associated genes identified by cDNA and tissue microarrays provide potentially valuable information on the metastasis of colorectal tumors. Overexpression of Grb2 may contribute to tumor growth, invasiveness and metastasis.Oncology Reports 06/2008; 19(5):1191-204. · 1.84 Impact Factor -
Article: Tumor size: a non-neglectable independent prognostic factor for gastric cancer.
[show abstract] [hide abstract]
ABSTRACT: The role of tumor size should not be neglected in the management of gastric cancer and its prognostic value needs precise reevaluation. The survival data of 513 patients who underwent radical resection between 2000 and 2005 were collected retrospectively. Tumor size, measured as the maximum diameter of tumor, was categorized into four subgroups (< or =2, < or =3, < or =5, >5 cm) using the method of minimizing the estimated average expected distance (AED) objective function. The prognostic value of tumor size and the correlation between tumor size and other clinicopathologic factors were investigated. In multivariate analysis, status of lymph nodes (P < 0.001), depth of invasion (P < 0.001), type of resection (P = 0.004), age (P = 0.008), tumor size (P = 0.014), and perioperative blood transfusion (P = 0.034) were confirmed as independent prognostic predictors for patients with gastric cancer. Log linear model suggested that the status of lymph nodes and the depth of invasion associated with the tumor size significantly. The tumor size is a non-neglectable independent prognostic factor for patients with gastric cancer and more attention should be paid to its role in the management of gastric cancer.Journal of Surgical Oncology 03/2008; 97(3):236-40. · 2.10 Impact Factor -
Article: [Time trends and characteristics of gastric cancer incidence in urban Shanghai].
[show abstract] [hide abstract]
ABSTRACT: To study the time trends during 1973 - 2004 and the current characteristics of gastric cancer incidence in Shanghai and to develop strategies for control and prevention. All data from the Malignant Cancer Registry System of Shanghai were retrieved and time trends of male and female incidence rates for gastric cancer in urban population from 1973 to 2004 were assessed by annual percentage change (APC) of the crude rates and age-adjusted rates. The APC was calculated by fitting a least squares regression line to the natural logarithm of the rates, using the calendar year as a regressor variable. Based on the computerized data from 2002 to 2004, the current characteristics of urban gastric cancer incidence were analyzed regarding sex, age, stage at diagonsis, histopathologic type and location of the tumor (s). The number and structure of population were obtained from Shanghai Municipal Public Security Bureau. The incidence rates were standardized under the world population. The constituent ratios were analyzed by Chi-square test. Statistical analyses were performed with the SPSS software package for Windows, version 10.0. Substantially and continuously decreasing trends were noticed in gastric cancer incidence during the past 32 years in urban Shanghai, both in males and in females. The age-standardized rates (ASR) dropped 54.4% in males and 37.6% in females. From 2002 to 2004, 7630 new cases of gastric cancer were registered in urban Shanghai with the ASRs of male and female gastric cancer as 27.4 and 14.0 per 100 000. Under the age of 40, the age-specific incidence was quite low that no differences were found between men and women. However, the incidence increased significantly after age of 40 and differences of increase were shown between the two sexes. About 46.1% of all the cases had detailed records of TNM stage, in which IV stage was the majority while I stage the least. About 74.1% of all the cases were diagnosed histopathologically and 71.7% of all had detailed records on histopathologic types. Adenocarcinoma was the most common type (76.8%), followed by signet ring cell carcinoma (9.4%). The proportions of adenocarcinoma and tubular adenocarcinoma were higher in males than in females while signet ring cell cancer was higher in females than in males. Intestinal type gastric cancer was the most prominent type in Lauren system. The proportion of male was higher than female in intestinal type whereas female was higher than male in diffused type. In lesion location, the antrum was the most common tumor site. The gastric antrum cancer of females was more common than males while the gastric cardia cancer presented quite the contrary. The proximal gastric cancer was more prevalent in males than in females whereas the distal gastric cancer was in opposite pattern. A dramatic decreasing trend during 1973 - 2004 and several current and interesting characteristics in view of gender, age, stage at diagnosis, histopathologic type and tumor location of gastric cancer in urban Shanghai were determined in this study, which might contribute to the development of control and prevention strategy for gastric cancer.Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 10/2007; 28(9):875-80. -
Article: [Consensus of experts on the management of malignant bowel obstruction in patients with advanced cancer].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 09/2007; 29(8):637-40. -
Article: [Quality of life and its influential factors of cancer patients in Shanghai].
[show abstract] [hide abstract]
ABSTRACT: Now the quality of life of cancer patients has become one of the end-points in cancer researches. It reflects the survival status and prognosis of cancer patients. This study was to determine the quality of life and its influential factors of cancer patients who live in communities in Shanghai, and to design suitable intervention and evaluate the effectiveness of community-based health care service. A total of 7,967 cancer patients who lived in communities in Shanghai were selected through searching Shanghai Cancer Patient Database by cluster sampling. Questionnaire with FACT-G Self-rating Scale was applied; 6,694 valid questionnaires were obtained. The scores of quality of life were calculated and analyzed with multiple linear regression model to determine the influential factors. The average score of quality of life of the 6 694 cancer patients was 107.62+/-18.77 (95% CI=107.17-108.07). Duration since diagnosis, stage at diagnosis, metastasis status, treatment effect, KPS score, and pain VAS score were main influential factors of quality of life of the cancer patients. Early diagnosis of cancer, improvement of the treatment effect, and providing community health care and analgesic services might improve the quality of life of cancer patients who live in communities.Ai zheng = Aizheng = Chinese journal of cancer 06/2007; 26(6):613-9. -
Article: [Study on the prevalence of depression among cancer patients and its influencing factors in Shanghai].
[show abstract] [hide abstract]
ABSTRACT: To determine the prevalence of depression among cancer patients and its influencing factors. We investigated 7967 cancer patients who lived in communities with cluster sampling based on 'Shanghai Cancer Patient Database'. They were investigated through questionnaires and completed the Zung Self-rating Scale. 6694 questionnaires were identified as 'qualified'. We calculated the prevalence of depression and determined the factors with logistic regression model. The prevalence rate of depression among cancer patients in communities was 24.74% (95% CI: 23.71% - 25.79%). Results from multi-factor analysis showed that duration since diagnosis, stages at diagnosis, metastasis, therapeutics, KPS scores, and pain VAS scores were the important factors. Early detection, improving the curative effect and providing community health services could reduce the prevalence of depression.Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 02/2007; 28(1):57-60. -
Article: [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
[show abstract] [hide abstract]
ABSTRACT: To compare the efficacy and safety of daily administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF), and a single subcutaneous injection of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF), a sustained-duration rhG-CSF, in chemotherapy-induced neutropenia. In the present randomized, open-label, match and cross-over study, enrolled 104 patients with previously untreated non-small cell lung cancer (NSCLC), breast cancer or non-Hodgkin's lymphoma and with normal bone marrow function from 13 centers were randomly divided into 2 matched groups, AB and BA group. Each patient received two cycles of chemotherapy of identical regimen. In the study cycle, the patients received a single subcutaneous injection of PEG-rhG-CSF 100 microg/kg on day 3; and in control cycle, daily subcutaneous infection of rhG-CSF 5 microg x kg(-1) x d(-1) began on day 3 and continued for 14 days or until the absolute neutrophil count (ANC) became > or = 5.0 x 10(9)/L twice after it decreased to the nadir. Efficacy and safety parameters were monitored. The incidence rates of ANC < 1.5 x 10(9)/L in the 103 evaluable study cycles and 100 evaluable control cycles were 30.00% and 20.00% with the duration of 2.39 days and 2.35 days respectively. The incidence rates of grade 3 neutropenia were 7.77% and 7.00%; and that of grade 4 neutropenia were 5.80% and 4.00% respectively in the trial and control cycles. However, all the difference mentioned above did not reached statistical significance. None of the patients experienced febrile neutropenia. The ANC nadir was (7.55 +/- 5.25) x 10(9)/L and (8.42 +/- 5.57) x 10(9)/L (P = 0.257) respectively after receiving PEG-rhG-CSF and rhG-CSF. Compared with that of rhG-CSF group, the ANC profile of PEG-rhG-CSF group exhibited limited "overshoot" of neutrophils after the nadir. Subgroup analysis according to disease type yielded similar results. The safety profiles of the PEG-rhG-CSF and rhG-CSF groups were similar. Musculoskeletal pain or arthralgia occurred in 16.5% of the study cycles and 26.00% of the control cycles (P = 0.963), mostly mild or moderate. Other adverse effects such as fever, fatigue, dizziness, gastrointestinal effects and injection-site pain, were transient and easily manageable. A single subcutaneous injection of PEG-rhG-CSF 100 microg/kg provides neutrophil support and a safety profile comparable to regimen of daily subcutaneous injection of rhG-CSF 5 microg x kg(-1) x d(-1) in Chinese patients receiving a variety of myelosuppressive chemotherapy regimens.Zhonghua yi xue za zhi 12/2006; 86(48):3414-9. -
Article: [Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma].
[show abstract] [hide abstract]
ABSTRACT: To investigate the expression levels of nm23, P53, and S100A4 in gastric carcinoma and their relationships with clinicopathologic parameters and metastasis potential. Pathological specimens from gastric carcinoma,matched para-tumor tissues, metastatic lymph node and distant metastatic tissues were examined for the expression levels of nm23, P53, and S100A4 proteins by tissue microarray technique and immunohistochemistry. The expression levels of P53 and S100A4 were upregulated (P< 0.01), while the expression of nm23 downregulated (P< 0.05) in gastric carcinoma compared with non-tumor tissues. S100A4 expression was significantly higher in distant metastatic tissues, while nm23 lower in metastatic lymph nodes than those in cancer tissues. Upregulating expression levels of nm23, P53, and S100A4 were significantly correlated with some malignant behaviour of gastric cancer. The expression rates of nm23+/P53+, P53+/S100A4+, and nm23+/S100A4+ immunohistochemical phenotypes were 48/74 (64.9%), 50/74 (67.6%), and 39/74 (52.7%). P53+/S100A4+, nm23+/S100A4+, and nm23+/P53+/S100A4+ phenotypes were associated with high metastasis potential of gastric cancer. Alteration of nm23, P53, and S100A4 expression may contribute to the development of gastric carcinoma. Nm23 and S100A4 proteins play a critical role in tumor metastasis. Co-detection of the expression of P53, nm23, and/or S100A4 can be used to evaluate high metastasis potential of gastric cancer.Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 03/2006; 9(2):165-9. -
Article: [Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia].
[show abstract] [hide abstract]
ABSTRACT: To investigate the effect and safety of zoledronic acid (Zoledex) in patients with cancer-induced hypercalcemia. Seventeen patients with cancer-induced hypercalcemia (corrected blood calcium > 2.70 mmol/L) were treated intravenously by 4 mg zoledex within 15 minutes on the first day. The corrected blood calcium was observed every 4 days in the following 28 days. The response rate was 94.1% (16/17). The mean corrected blood calcium became normal after the first dose of zoledex (P < 0.01). The lowest value was found on the fourteenth day after treatment. The main side effects consisted of fever (29.4%, 5/17), hypocalcemic tetany (11.8%, 2/17) and arythmia (5.9%, 1/17). Zoledex is effective and safe in the treatment of patient with cancer-induced hypercalcemia.Zhonghua zhong liu za zhi [Chinese journal of oncology] 10/2005; 27(10):632-4. -
Article: [Cryosurgical ablation for 23 cases of prostate cancer guided by rectal ultrasound].
[show abstract] [hide abstract]
ABSTRACT: To detect the short-term clinical and side effects of cryosurgical ablation for prostate cancer. The ENDOCAm cryosurgical system with 2 mm Cryo-probes was used to treat the prostate cancer guided by rectal ultrasonic. 1. Completeness of freeze; 2. Complications; 3. The changes of PSA and PSMA before and after operation were observed respectively. 1. The completeness of freeze rate and non-completeness of freeze rate were 34.8% (8/23) and 65.2% (15/23) showed by MRI 3 weeks later after operation; the biopsy results showed that tumor positive rates in completeness of freeze group and non-completeness of freeze group were 0 and 20% (3/15) respectively after 6 months. 2. The incontinence rate was 13%, and all recovered during 1 month; and the erectile dysfunction rate post-operation was 56.2% (9/16). 3. The levels of PSA before and after cryosurgical ablation were (32.98 +/- 35. 50) microg/L, (11.65 +/- 26. 51) microg/L respectively (P < 0.05). PSMA increased significantly after the cryosurgical ablation. The short-term curative effects of cryosurgical ablation, which guided by rectal ultrasound for prostate cancer is satisfied with low complication rate and minor vulnus.Zhonghua nan ke xue = National journal of andrology 09/2005; 11(9):670-3.
Top co-authors
Top Journals
Institutions
-
2007–2011
-
Second Military Medical University, Shanghai
Shanghai, Shanghai Shi, China
-
-
2005
-
Academy of Military Medical Sciences
Tianjin, Tianjin Shi, China
-
-
2003
-
Fudan University
Shanghai, Shanghai Shi, China
-
